...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.
【24h】

Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.

机译:在2F5 VH x VL敲入小鼠中拯救HIV-1广泛表达中和抗体的B细胞,揭示了多种耐受性对照。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The HIV-1 broadly neutralizing Ab (bnAb) 2F5 has been shown to be poly-/self-reactive in vitro, and we previously demonstrated that targeted expression of its VDJ rearrangement alone was sufficient to trigger a profound B cell developmental blockade in 2F5 V(H) knockin (KI) mice, consistent with central deletion of 2F5 H chain-expressing B cells. In this study, we generate a strain expressing the entire 2F5 bnAb specificity, 2F5 V(H) x V(L) KI mice, and find an even higher degree of tolerance control than observed in the 2F5 V(H) KI strain. Although B cell development was severely impaired in 2F5 V(H) x V(L) KI animals, we demonstrate rescue of their B cells when cultured in IL-7/BAFF. Intriguingly, even under these conditions, most rescued B cell hybridomas produced mAbs that lacked HIV-1 Envelope (Env) reactivity due to editing of the 2F5 L chain, and the majority of rescued B cells retained an anergic phenotype. Thus, when clonal deletion is circumvented, kappa editing and anergy are additional safeguards preventing 2F5 V(H)/V(L) expression by immature/transitional B cells. Importantly, 7% of rescued B cells retained 2F5 V(H)/V(L) expression and secreted Env-specific mAbs with HIV-1-neutralizing activity. This partial rescue was further corroborated in vivo, as reflected by the anergic phenotype of most rescued B cells in 2F5 V(H) x V(L) KI x Emu-Bcl-2 transgenic mice and significant (yet modest) enrichment of Env-specific B cells and serum Igs. The rescued 2F5 mAb-producing B cell clones in this study are the first examples, to our knowledge, of in vivo-derived bone marrow precursors specifying HIV-1 bnAbs and provide a starting point for design of strategies aimed at rescuing such B cells.
机译:HIV-1广泛中和抗体(bnAb)2F5在体外具有多反应性/自反应性,我们之前证明了仅对其VDJ重排进行靶向表达就足以在2F5 V中引发深刻的B细胞发育阻断(H)敲入(KI)小鼠,与表达2F5 H链的B细胞的中央缺失相一致。在这项研究中,我们生成了一个表达2F5 bnAb整体特异性的菌​​株,即2F5 V(H)x V(L)KI小鼠,并且发现了比2F5 V(H)KI菌株更高的耐受性控制程度。虽然在2F5 V(H)x V(L)KI动物中B细胞发育受到严重损害,但我们在IL-7 / BAFF中培养时证明了其B细胞的抢救。有趣的是,即使在这些条件下,由于2F5 L链的编辑,大多数获救的B细胞杂交瘤所产生的mAb也缺乏HIV-1包膜(Env)反应性,并且大部分获救的B细胞仍保留了无反应的表型。因此,当避免克隆缺失时,κ编辑和无反应性是防止未成熟/过渡性B细胞表达2F5 V(H)/ V(L)的额外保障。重要的是,有7%的获救B细胞保留2F5 V(H)/ V(L)表达并分泌具有HIV-1中和活性的Env特异性mAb。在2F5 V(H)x V(L)KI x Emu-Bcl-2转基因小鼠中大多数被拯救的B细胞的无能表型反映了Env-特异性B细胞和血清Igs。据我们所知,本研究中挽救的产生2F5 mAb的B细胞克隆是指定HIV-1 bnAb的体内骨髓前体的第一个例子,为设计旨在拯救此类B细胞的策略提供了起点。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号